| # | Title | Journal | Year | Citations |
|---|
| 1 | Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer | JAMA Oncology | 2019 | 285 |
| 2 | Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials | Head and Neck | 2016 | 203 |
| 3 | Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers | Blood | 2021 | 59 |
| 4 | A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852) | Annals of Oncology | 2017 | 57 |
| 5 | Ibrutinib in CLL: a focus on adverse events, resistance, and novel approaches beyond ibrutinib | Annals of Hematology | 2017 | 55 |
| 6 | Vitamin D in hematological disorders and malignancies | European Journal of Haematology | 2017 | 54 |
| 7 | Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions | Blood | 2022 | 50 |
| 8 | γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer | British Journal of Cancer | 2012 | 47 |
| 9 | Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy | Transplantation and Cellular Therapy | 2021 | 45 |
| 10 | Enhancement of paclitaxel activity against hormone-refractory prostate cancer cells in vitro and in vivo by quinacrine | British Journal of Cancer | 1997 | 44 |
| 11 | Neuroleukemiosis: Case report of leukemic nerve infiltration in acute lymphoblastic leukemia | Muscle and Nerve | 2008 | 43 |
| 12 | Paclitaxel (taxol) inhibits protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells | Molecular Pharmacology | 1995 | 43 |
| 13 | Specific Labeling of Isoprenylated Proteins: Application to Study Inhibitors of the Post-translational Farnesylation and Geranylgeranylation | Biochemical and Biophysical Research Communications | 1995 | 42 |
| 14 | Burkitt Lymphoma International Prognostic Index | Journal of Clinical Oncology | 2021 | 37 |
| 15 | Indoleamine-2,3-Dioxygenase in Non–Small Cell Lung Cancer | American Journal of Surgical Pathology | 2018 | 36 |
| 16 | Synergistic hematopoietic growth factors | International Journal of Cell Cloning | 1986 | 32 |
| 17 | Anthracycline- and trastuzumab-induced cardiotoxicity: a retrospective study | Medical Oncology | 2016 | 32 |
| 18 | A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites | Cancer Immunology, Immunotherapy | 2016 | 30 |
| 19 | Cancer treatment-related cardiac toxicity: prevention, assessment and management | Medical Oncology | 2016 | 27 |
| 20 | Umbilical cord blood: The promise and the uncertainty | Stem Cells Translational Medicine | 2020 | 26 |
| 21 | CD97 is a critical regulator of acute myeloid leukemia stem cell function | Journal of Experimental Medicine | 2019 | 24 |
| 22 | Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia | Nature Communications | 2022 | 23 |
| 23 | A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodes | Nature Communications | 2014 | 21 |
| 24 | Reconstitution of Estrogen-Dependent Transcriptional Activation of an Adenoviral Target Gene in Select Regions of the Rat Mammary Gland1 | Endocrinology | 1998 | 19 |
| 25 | Stereotactic radiosurgery in the treatment of brain metastases from gastrointestinal primaries | Journal of Neuro-Oncology | 2015 | 17 |
| 26 | Thalidomide Plus Dexamethasone Versus Dexamethasone Alone in Newly Diagnosed Multiple Myeloma (E1A00): Results of a Phase III Trial Coordinated by the Eastern Cooperative Oncology Group. | Blood | 2004 | 16 |
| 27 | Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study | Urologic Oncology: Seminars and Original Investigations | 2018 | 15 |
| 28 | Peripheral stem cell collection: From leukocyte growth factor to removal of catheter | Journal of Clinical Apheresis | 2014 | 14 |
| 29 | Safety and Anti-Tumor Activity of Plamotamab (XmAb13676), an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Subjects with Relapsed/Refractory Non-Hodgkin's Lymphoma | Blood | 2021 | 13 |
| 30 | Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity | Journal of Hematology and Oncology | 2021 | 13 |
| 31 | <p>A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexate</p> | Cancer Management and Research | 2019 | 12 |
| 32 | Implementation of a Model-Based Design in a Phase Ib Study of Combined Targeted Agents | Clinical Cancer Research | 2017 | 11 |
| 33 | Bispecific Antibody Armed Metabolically Enhanced Headless CAR T Cells | Frontiers in Immunology | 2021 | 11 |
| 34 | Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma | Blood Advances | 2021 | 11 |
| 35 | <p>Enasidenib in acute myeloid leukemia: clinical development and perspectives on treatment</p> | Cancer Management and Research | 2019 | 10 |
| 36 | Treatment of hematological malignancies with T cell redirected bispecific antibodies: current status and future needs | Expert Opinion on Biological Therapy | 2019 | 10 |
| 37 | Treatment of Refractory ALK Rearranged Anaplastic Large Cell Lymphoma With Alectinib | Clinical Lymphoma, Myeloma and Leukemia | 2019 | 10 |
| 38 | Striving toward Improved Outcomes for Surgically Resectable Non-Small Cell Lung Cancer: the Promise and Challenges of Neoadjuvant Immunotherapy | Current Oncology Reports | 2020 | 10 |
| 39 | <p>Evaluating Nelipepimut-S in the Treatment of Breast Cancer: A Short Report on the Emerging Data</p> | Breast Cancer: Targets and Therapy | 2020 | 10 |
| 40 | Thrombophilia: What's a Practitioner to Do? | Hematology American Society of Hematology Education Program | 2001 | 10 |
| 41 | Addressing a New Challenge in Chronic Lymphocytic Leukemia: Outcomes of Therapies after Exposure to Both a Covalent Bruton's Tyrosine Kinase Inhibitor and Venetoclax | Blood | 2021 | 10 |
| 42 | miR-181a is a novel player in the STAT3-mediated survival network of TCRαβ+ CD8+ T large granular lymphocyte leukemia | Leukemia | 2022 | 10 |
| 43 | Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML | Blood Advances | 2021 | 9 |
| 44 | CNS Prophylaxis during Front-Line Therapy in Aggressive Non-Hodgkin Lymphomas: Real-World Outcomes and Practice Patterns from 19 US Academic Institutions | Blood | 2020 | 9 |
| 45 | Recent developments in the implementation of novel designs for early-phase combination studies | Annals of Oncology | 2015 | 8 |
| 46 | Evaluation of cardiomyopathy in acute myeloid leukemia patients treated with anthracyclines | Journal of Oncology Pharmacy Practice | 2020 | 8 |
| 47 | Oral Regimen for Urine Alkalization in Patients Receiving High Dose Methotrexate during a National Shortage of Intravenous Sodium Bicarbonate | Blood | 2018 | 8 |
| 48 | Reconstitution of Estrogen-Dependent Transcriptional Activation of an Adenoviral Target Gene in Select Regions of the Rat Mammary Gland | Blood | 0 | 8 |
| 49 | Health related quality of life for multiple myeloma patients according to treatment strategy after autologous stem cell transplant: a cross-sectional study using EORTC, EQ-5D and MY-20 scales | Leukemia and Lymphoma | 2019 | 7 |
| 50 | Outcomes of Patients with Relapsed Mantle Cell Lymphoma Treated with Venetoclax: A Multicenter Retrospective Analysis | Blood | 2020 | 7 |
